Resources Repository
-
ReportPublication 2017DCP3: Major Infectious Diseases
This report from the World Bank is the sixth volume of the Disease Control Priorities, …
This report from the World Bank is the sixth volume of the Disease Control Priorities, third edition (DCP3) series and examines the burden of infectious diseases, which remain a leading cause of death globally, especially for children and adolescents. This report identifies feasible and cost-effective platforms to prevent and treat diseases like HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and tropical diseases. This volume also emphasizes the importance of addressing…
Evidence Synthesis | Cost-Effectiveness Analysis | Health/Medicine | Costing Methods | Health Outcomes | Infectious Diseases | Health Systems | Global Governance | Economics/Finance | Global -
ReportPublication 2017Economic Value of Informal Mental Health Caring
Caregivers, family and friends play a significant role in supporting people with mental illness, and …
Caregivers, family and friends play a significant role in supporting people with mental illness, and it has long been recognized that informal carers constitute a significant ‘hidden’ workforce in Australia. Faced as Australia is with an ageing population and burgeoning chronic disease, data on the contribution that carers make and the consequent savings to governments and other ‘payers’ need to be articulated. This report attempts to put a ‘value’ on informal caring for those with mental illness.…
Benefit-Cost Analysis | Cost-Effectiveness Analysis | Health/Medicine | Preferences/Values | Costing Methods | Health Outcomes | Chronic Disease/Risk | Mental Health | Health Systems | Economics/Finance | Oceania -
ReportPublication 2016Cost-Effectiveness of Mental, Neurological, and Substance Use Disorders
This report chapter reviews the available cost-effectiveness evidence for the different levels and underpinning strategies of …
This report chapter reviews the available cost-effectiveness evidence for the different levels and underpinning strategies of the mental health care system, with a focus on information generated in or for lower and middle income countries. First, the chapter reviews the economic evidence for mental health prevention and protection at the population and community levels of the health and welfare system, including legislative, regulatory, and informational measures at the public policy level (population platform), as well as…
Evidence Synthesis | Cost-Effectiveness Analysis | Health/Medicine | Chronic Disease/Risk | Health Systems | Global -
ReportPublication 2015Chapter 4: Cervical Cancer
This chapter focuses on the possibility of primary prevention of cervical cancer as a result …
This chapter focuses on the possibility of primary prevention of cervical cancer as a result of the introduction of two commercially available vaccines against human papillomavirus (HPV). Few low- and middle-income countries (LMICs) have initiated or sustained cytology-based cervical cancer prevention programs, and these countries experience very high incidence and mortality rates. Fortunately, alternative strategies to prevent cervical cancer have been investigated and extensively evaluated in these settings. The authors report findings from cost-effectiveness analyses…
Mathematical Models | Cost-Effectiveness Analysis | Health/Medicine | Infectious Diseases | Chronic Disease/Risk | Health Systems | Clinical Care | Science/Technology | Global -
ReportPublication 2023Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health
This ISPOR Task Force report examines the integration of patient preferences into healthcare decision-making, emphasizing …
This ISPOR Task Force report examines the integration of patient preferences into healthcare decision-making, emphasizing the growing significance of both qualitative and quantitative methods for studying these preferences. The report synthesizes current best practices to enhance the utility and impact of patient-preference studies. The methods involved reviewing existing literature and practices to construct the ISPOR Roadmap for Patient Preferences in Decision Making. This roadmap encourages collaboration among researchers, decision-makers, patients, patient groups, and other stakeholders.…
Evidence Synthesis | Health/Medicine | Preferences/Values | Health Outcomes -
EditorialPublication 2023Societal Perspective: Themed Issue on Productivity Costs, Consumption Costs, Informal Care Costs
Economic evaluations in healthcare assess the costs and benefits of new interventions, particularly pharmaceuticals, to …
Economic evaluations in healthcare assess the costs and benefits of new interventions, particularly pharmaceuticals, to inform funding and reimbursement decisions. These evaluations compare a new intervention against a relevant comparator, with the relevance of costs and benefits depending on the chosen perspective. The healthcare perspective, which assumes a fixed budget and aims to maximize health outcomes, considers only health impacts and costs within the budget. This approach simplifies the evaluation but may lead to suboptimal…
Cost-Effectiveness Analysis | Health/Medicine | Costing Methods -
BriefPublication 2023Simulation Modeling to Guide Priority Setting in Global Maternal Health
This study developed the Global Maternal Health (GMatH) microsimulation model to evaluate maternal health policy …
This study developed the Global Maternal Health (GMatH) microsimulation model to evaluate maternal health policy interventions across 200 countries and territories from 1990 to 2050. It addresses challenges in measuring maternal mortality by simulating individual women's reproductive lifecycles. Various interventions, including family planning and facility-based care, were simulated to compare against a baseline scenario projecting the global maternal mortality ratio (MMR) to decrease to 167 per 100,000 live births by 2030. Results suggest that while…
Cost-Effectiveness Analysis | Health/Medicine | Microsimulation | Maternal/Reproductive Health | Policy/Regulation | Global -
ReportPublication 2022Investment Case for New Tuberculosis Vaccines
Investing more financial resources to accelerate scientific progress toward an effective tuberculosis (TB) vaccine will …
Investing more financial resources to accelerate scientific progress toward an effective tuberculosis (TB) vaccine will save lives, fight antimicrobial resistance, advance health equity, improve economic growth, and bring a substantial return on investment. This World Health Organization (WHO) report describes the full value proposition for new TB vaccines. These analyses articulate the broader economic impacts of new TB vaccines to guide global stakeholders when making investment decisions for novel TB vaccines and to plan for…
Cost-Effectiveness Analysis | Health/Medicine | Infectious Diseases | Economics/Finance | Global -
EditorialPublication 2021Scientific and Regulatory Challenges in Designing mHealth Interventions
Scientists looking for innovative ways to deliver health care have long searched for mechanisms that …
Scientists looking for innovative ways to deliver health care have long searched for mechanisms that can enable the right intervention to be delivered at the right time. Traditional delivery mechanisms have been limited both to the availability of a provider (e.g., a physician) and the location of care (e.g., a hospital or outpatient clinic). In recent years, however, numerous technological advancements—including wearable devices, mobile technologies, and the widespread development and use of user-friendly smartphone applications—have…
Technology Assessment | Health/Medicine | Science/Technology | North America